Mon, Dec 22, 2014, 8:20 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • surfntravel surfntravel Nov 19, 2013 6:01 PM Flag

    Where revenue can come from

    You have patents due any day now right?, you have centers all over the world? You have paid patient research at Regen, and a ton of happy camper vocal supporters that have had the procedure. This a Clarion call man, The trumpets are sounding, the army of public wanting this research is marching regardless if your willing to get in front of the steady footsteps or not. The FDA will get trampled in the end regardless if you get up in front or not. Its coming, the public will not wait to know if this is the future of medicine. They are tired of the drugs and the advertisements rattling off a laundry list of side effects. The body using its own cells concentrated on the attack. Get going..

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Awesome post man! I absolutely agree with everything u said. They have to take advantage of this opportunity. I know they will.

      Sentiment: Strong Buy

    • The stock price has finally bounced back and has reached price levals not seen since late november which was around the time that this thread began. the stock fell but now the stock is moveing back up. over all the period from November 19 to January 21 will have been one long sideways pattern. i think the stock price has much future potential and there still remains a hugh amount of oppurtunity here for new investors if they can find a proper entry point. a few more weeks like the past few weeks we had and the stock price could reach 1 cent again. i know it seems un realistic but it could happen.

 
SVFC
0.0003+0.0001(+57.89%)Dec 22 3:58 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Henry Schein, Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Sirona Dental Systems Inc.
NASDAQMon, Dec 22, 2014 3:59 PM EST